Concepedia

Birgit Jaber

BJ

6

Publications

319

Citations

6

H-Index

2018

Active since

Affiliations

Roche (Switzerland)(Current)

Roche (United Kingdom)

University College London

Stanford University

Great Ormond Street Hospital

Birgit Jaber is an author at Roche (Switzerland) specializing in neurology, rehabilitation, and orthopaedics.

Top concepts

Publications per year

2018–2025

6

Publications

6

A phase 1 healthy male volunteer single escalating dose study of the pharmacokinetics and pharmacodynamics of risdiplam (RG7916, RO7034067), a <i>SMN2</i> splicing modifier

Stefan Sturm, Andreas Guenther, Birgit Jaber et al. · British Journal of Clinical Pharmacology · 2018 · 98 citations · Full text

Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial

Riccardo Masson, Maria Mazurkiewicz-Bełdzińska, Kristy Rose et al. · The Lancet Neurology · 2022 · 96 citations · Full text

, , +6

Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study

Claudia A. Chiriboga, Claudio Bruno, Tina Duong et al. · Neurology and Therapy · 2023 · 52 citations · Full text

Risdiplam treatment has not led to retinal toxicity in patients with spinal muscular atrophy

Robert C. Sergott, Giulia Maria Amorelli, Giovanni Baranello et al. · Annals of Clinical and Translational Neurology · 2020 · 34 citations · Full text

JEWELFISH: 24-month results from an open-label study in non-treatment-naïve patients with SMA receiving treatment with risdiplam

Claudia A. Chiriboga, Claudio Bruno, Tina Duong et al. · Journal of Neurology · 2024 · 25 citations · Full text

Rows per page

1–5 of 6